RICHELDI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.831
EU - Europa 6.148
AS - Asia 2.106
SA - Sud America 47
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 16
Totale 23.205
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.768
GB - Regno Unito 2.360
IT - Italia 1.253
SE - Svezia 767
CN - Cina 753
SG - Singapore 540
DE - Germania 507
UA - Ucraina 474
TR - Turchia 280
HK - Hong Kong 273
FI - Finlandia 263
FR - Francia 166
BG - Bulgaria 165
IN - India 72
CA - Canada 51
RU - Federazione Russa 50
ID - Indonesia 44
BE - Belgio 30
KR - Corea 29
VN - Vietnam 28
BR - Brasile 26
IR - Iran 22
NG - Nigeria 20
NL - Olanda 20
ZA - Sudafrica 19
IE - Irlanda 15
PK - Pakistan 14
AU - Australia 13
EU - Europa 13
IQ - Iraq 12
CH - Svizzera 10
MY - Malesia 10
MX - Messico 9
PL - Polonia 9
AL - Albania 8
ES - Italia 8
JP - Giappone 8
TW - Taiwan 8
CL - Cile 6
TH - Thailandia 6
CO - Colombia 5
CZ - Repubblica Ceca 5
LT - Lituania 5
RO - Romania 5
AT - Austria 4
GR - Grecia 4
HR - Croazia 4
PE - Perù 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BD - Bangladesh 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
AR - Argentina 2
BO - Bolivia 2
BZ - Belize 2
DK - Danimarca 2
EC - Ecuador 2
LV - Lettonia 2
MG - Madagascar 2
AD - Andorra 1
AE - Emirati Arabi Uniti 1
BY - Bielorussia 1
EE - Estonia 1
JM - Giamaica 1
KH - Cambogia 1
MO - Macao, regione amministrativa speciale della Cina 1
OM - Oman 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
Totale 23.205
Salva come PNG Salva come JPEG
Città #
Fairfield 2.176
Southend 2.014
Woodbridge 1.472
Houston 1.133
Ashburn 1.102
Jacksonville 955
Chandler 921
Santa Clara 835
Seattle 813
Dearborn 752
Wilmington 707
Ann Arbor 696
Cambridge 690
Nyköping 452
Singapore 395
Hong Kong 267
Beijing 234
San Diego 191
Modena 184
Princeton 172
Sofia 164
Eugene 158
Izmir 123
New York 108
Helsinki 106
London 71
Milan 66
Shanghai 58
Des Moines 57
Naples 51
Palermo 50
Redwood City 49
Bremen 46
Rome 45
Boardman 34
Jakarta 33
Brussels 30
Norwalk 28
Phoenix 28
Dong Ket 26
Hefei 26
Frankfurt am Main 25
Guangzhou 23
Florence 22
Bari 20
Kunming 20
Falls Church 19
San Mateo 19
Turin 19
Leawood 17
San Francisco 17
Chicago 15
Nanjing 15
Philadelphia 15
Jinan 14
Bologna 13
Dublin 13
Indiana 13
Kilburn 13
Mountain View 13
Verona 13
Hounslow 12
Toronto 12
Chennai 11
Mumbai 11
Lagos 10
Los Angeles 10
Nanchang 10
Ottawa 10
Pescara 10
Wuhan 10
Chiswick 9
Holly 9
Seongnam 9
Lucca 8
San Jose 8
Tirana 8
Zhengzhou 8
Lahore 7
Moscow 7
Napoli 7
Perugia 7
Pistoia 7
Saint Petersburg 7
Seoul 7
Andover 6
Auburn Hills 6
Basrah 6
Catania 6
Chongqing 6
Dallas 6
Durban 6
Hangzhou 6
Lusciano 6
Paris 6
Pioltello 6
Rimini 6
Washington 6
Abuja 5
Ardabil 5
Totale 18.158
Salva come PNG Salva come JPEG
Nome #
Malattie infiltrative diffuse del polmone 828
Multidrug-resistant tuberculosis outbreak in an Italian prison: Tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays 679
Clinical use of Levofloxacin in the long-term treatment of drug resistant tuberculosis. 315
Non-steroid agents for idiopathic pulmonary fibrosis 276
Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist 269
Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments 238
Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study 236
"Velcro-type" crackles predict specific radiologic features of fibrotic interstitial lung disease 230
Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. 227
Atypical lipomatous tumour (lipoma-like well-differentiated liposarcoma) arising in a pulmonary hamartoma and clinically presenting with pneumothorax 217
Use of Pirfenidone in Idiopathic Pulmonary Fibrosis: A Case Study 217
Prior tuberculin skin testing does not boost QuantiFERON-TB results in paediatric contacts 212
Room size is the major determinant for tuberculin conversion in health care workers exposed to a multidrug-resistant tuberculosis patient 211
Efficacy of hormonal suppression in a patient with chyluria due to lymphangioleiomyomatosis 210
Aortic pulse wave velocity measurement in systemic sclerosis patients. 209
A culture-proven case of community-acquired Legionella pneumonia apparently classified as nosocomial: diagnostic and public health implications 205
Comparison of the tubercolin skin test and the ellispot blood test for the diagnosis of latent tuberculosis infection in pre-transplant dialysis patients 204
Rifabutin for treating pulmonary tuberculosis. 199
Occurrence of idiopathic pulmonary fibrosis during immunosuppressive treatment: a case report 197
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 194
Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis 193
T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure 192
Role Of The QFT-IT Assay For The Diagnosis Of Latent Tuberculosis Infection Among Adult Immigrants 192
Assessing the treatment effect from multiple trials in idiopathic pulmonary fibrosis. 190
Amyotrophic lateral sclerosis and sarcoidosis: a difficult differential diagnosis. 189
A quantitative proteomic approach to identify significantly altered protein networks in the serum of patients with lymphangioleiomyomatosis (LAM) 187
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis 187
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 186
Unexpected identification of bilateral masses in an asymptomatic heavy smoker. 186
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis 185
Pulmonary fibrosis and the many faces of UIP 185
Mindfulness-based stress reduction in patients with interstitial lung diseases: a pilot, single-centre observational study on safety and efficacy 182
Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials 180
Lung fibrosis, bone marrow fibrosis and liver cirrhosis: A Short Telomere Syndrome or a casual association? 178
Novel drug targets for idiopathic pulmonary fibrosis 177
Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections 176
Using ELISpot technology to improve the diagnosis of tuberculosis infection: from the bench to the T-SPOT.TB assay 175
T-cell-based diagnosis of neonatal multidrug-resistant latent tuberculosis infection. 174
Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis. 174
Environmental triggers and susceptibility factors in idiopathic granulomatous diseases. 172
MDR1 C3435T genetic polymorphism does not influence the response to antiretroviral therapy in drug-naive HIV-positive patients 171
Management of Idiopathic Pulmonary Fibrosis 170
Smoking-related interstitial lung disease 168
Sarcoidosis: challenging diagnostic aspects of an old disease. 167
Emerging drugs for idiopathic pulmonary fibrosis. 167
Quantiferon-TB Gold In-Tube Tests In Hospital Health Care Workers: A Five Years Experience 167
Management of idiopathic pulmonary fibrosis. 167
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 165
Prevalence and prognosis of unclassifiable interstitial lung disease 162
Home Oxygen Saturation Monitoring And Quality Of Life Evaluation In Patients With Idiopathic Pulmonary Fibrosis: Preliminary Results From A Prospective Multicenter Trial 162
The big clinical trials in idiopathic pulmonary fibrosis. 161
Macrolides in the treatment of asthma and cystic fibrosis 159
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias 158
MOLECULAR DIAGNOSIS OF TUBERCULOSIS 157
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 155
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. 153
Performance of tests for latent tuberculosis in different groups of immunocompromised patients 152
Repeated Quantiferon-TB Gold In-Tube Tests In Routine Clinical Practice: A Five Years Experience 152
Treating idiopathic pulmonary fibrosis: current opportunities and future challenges. 151
Immunomodulatory agents for idiopathic pulmonary fibrosis. 150
Idiopathic pulmonary fibrosis: current challenges and future perspectives 150
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. 149
Hot of the breath: mortality as a primary end-point in IPF treatment trials: the best is the enemy of the good 149
Acute exacerbations of chronic obstructive pulmonary disease: are antibiotics needed? 148
Genetic testing in diffuse parenchymal lung disease 147
Performance of commerical blood tests for the diagnosis of latent tuberculosis infection in children and adolescents 147
Role of the quantiferon-TB test in ruling out pleural tuberculosis: a multi-centre study. 147
Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges. 146
Fibulin-1 predicts disease progression in patients with idiopathic pulmonary fibrosis 146
Mapping the future for pulmonary fibrosis: report from the 17th International Colloquium on Lung and Airway Fibrosis 145
The role of biomarkers in low respiratory tract infections. 144
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 144
Pirfenidone in idiopathic pulmonary fibrosis: the CAPACITY program. 143
End of an ERA: lessons from negative clinical trials in idiopathic pulmonary fibrosis. 142
To BAL or not to BAL: is this a problem in diagnosing IPF? 139
Early diagnosis of subclinical multi drug-resistant tuberculosis 137
Screening dell’infezione tubercolare latente in operatori sanitari con QuantiFERON-TB e test cutaneo tubercolinico [Screening of latent tuberculosis infection in health care workers by QuantiFERON-TB and tuberculin skin test] 137
Exploring the immune response against Mycobacterium tuberculosis for a better diagnosis of the infection. 136
Inappropriatezza prescrittiva dell'ossigenoterapia domiciliare a lungo termine 136
The complex interrelationships between chronic lung and liver disease: a review. 135
HLA-DPB1 Glutamate 69: a genetic marker of beryllium disease 133
A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. 133
Il cloroformio nell'aria alveolare di frequentatori di piscine coperte. 133
Churg-Strauss syndrome in a case of asthma 133
Interferon gamma assays for tuberculosis 132
Immunogenetic basis of environmental lung disease: lessons from the berylliosis model 132
An update on the diagnosis of tuberculosis infection 132
Impact of a T cell-based blood test for tuberculosis infection on clinical decision-making in routine practice 132
Idiopathic pulmonary fibrosis: recent trials and current drug therapy 132
Macrolides for chronic asthma. 130
Corticosteroid and immunomodulatory agents in idiopathic pulmonary fibrosis 130
Tubercolosi 130
Identification Of Potential Candidate Biomarkers In Lymphangioleiomyomatosis Using ITRAQ Proteomic Technology 130
Tuberculosis infection in foreign-born children: a screening survey based on skin and blood testing. 129
Challenges in idiopathic interstitial lung disease 129
Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial 129
Tuberculosis diagnostic tests: Sensitivity, specificity, and comparing apples with apples 128
Interaction of genetic and exposure factors in the prevalence of berylliosis 124
Mycobacterium tuberculosis induces CCL18 expression in human macrophages 124
The role of bronchoalveolar lavage cellular analysis in the diagnosis of interstitial lung diseases 123
Totale 17.912
Salva come PNG Salva come JPEG
Categoria #
all - tutte 93.536
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.536
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.168 0 0 0 0 613 839 921 521 519 190 302 263
2020/20213.561 347 180 355 291 366 262 292 444 165 417 243 199
2021/20222.903 86 488 275 221 59 87 200 108 293 208 525 353
2022/20232.694 324 274 169 241 317 402 47 292 331 81 116 100
2023/20242.023 62 129 124 173 372 244 245 244 67 47 128 188
2024/20251.780 212 90 84 417 977 0 0 0 0 0 0 0
Totale 23.400